The case law distinguishes between so-called “unpredictable arts” (e.g., the biological, chemical, and pharmaceutical arts) ...

Brain diagnostics company Amprion recently closed $6 million from a $15 million total Series B financing round to expand the company's commercial reach ...

Cassava then released the altered data in a press release and investor deck, which led the SEC to allege that the company and ...

Sales of Eli Lilly’s blockbuster weight loss drug Zepbound came ... of the owner of brands Mac and Clinique from January 1, ...

They just revealed what they believe are the 10 best stocks for investors to buy right now… See the 10 stocks » *Stock ...

The Eli Lilly (NYSE:LLY) share price fell by double digits in the S&P 500 today, leaving this Fool debating whether he should ...

demanded answers from Pfizer and Eli Lilly about their relationships ... A review of contributions by chief executive officers of member companies and board members of the Pharmaceutical ...

RADNOR, Pa., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the appointment of John Reynders, PhD, to its Board of ...

The shortages caught the attention of patient advocates and members of Congress who have ... Novo Nordisk, Eli Lilly and Sanofi. Last spring, Eli Lilly reported its drugs Humalog and insulin ...

The shortages caught the attention of patient advocates and members of Congress who have demanded answers ... Three drug ...

STOCKHOLM, SE / ACCESSWIRE / November 11, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced that its interim report for the period January - Septem ...

STRIDES is being conducted in collaboration with Eli Lilly & Company’s Chorus clinical development ... with option grants issued in 2024 to employees, executives, board members and advisors. Net loss ...